Twist Bioscience (TWST) Competitors $40.10 +2.39 (+6.33%) As of 12:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TWST vs. QGEN, ROIV, RVMD, LNTH, BBIO, TGTX, LEGN, SRPT, TLX, and ADMAShould you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Qiagen (QGEN), Roivant Sciences (ROIV), Revolution Medicines (RVMD), Lantheus (LNTH), BridgeBio Pharma (BBIO), TG Therapeutics (TGTX), Legend Biotech (LEGN), Sarepta Therapeutics (SRPT), Telix Pharmaceuticals Limited American Depositary Shares (TLX), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry. Twist Bioscience vs. Qiagen Roivant Sciences Revolution Medicines Lantheus BridgeBio Pharma TG Therapeutics Legend Biotech Sarepta Therapeutics Telix Pharmaceuticals Limited American Depositary Shares ADMA Biologics Qiagen (NYSE:QGEN) and Twist Bioscience (NASDAQ:TWST) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, community ranking, profitability, valuation and risk. Which has better earnings and valuation, QGEN or TWST? Qiagen has higher revenue and earnings than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQiagen$1.98B4.85$83.59M$0.36119.91Twist Bioscience$330.19M7.24-$208.73M-$3.38-11.86 Is QGEN or TWST more profitable? Qiagen has a net margin of 4.23% compared to Twist Bioscience's net margin of -59.76%. Qiagen's return on equity of 13.92% beat Twist Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Qiagen4.23% 13.92% 8.40% Twist Bioscience -59.76%-32.69%-25.25% Which has more risk & volatility, QGEN or TWST? Qiagen has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.34, indicating that its share price is 134% more volatile than the S&P 500. Does the MarketBeat Community believe in QGEN or TWST? Qiagen received 144 more outperform votes than Twist Bioscience when rated by MarketBeat users. Likewise, 60.00% of users gave Qiagen an outperform vote while only 58.99% of users gave Twist Bioscience an outperform vote. CompanyUnderperformOutperformQiagenOutperform Votes24960.00% Underperform Votes16640.00% Twist BioscienceOutperform Votes10558.99% Underperform Votes7341.01% Does the media favor QGEN or TWST? In the previous week, Twist Bioscience had 1 more articles in the media than Qiagen. MarketBeat recorded 15 mentions for Twist Bioscience and 14 mentions for Qiagen. Twist Bioscience's average media sentiment score of 1.36 beat Qiagen's score of 0.96 indicating that Twist Bioscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Twist Bioscience 10 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate QGEN or TWST? Qiagen currently has a consensus price target of $48.42, indicating a potential upside of 12.16%. Twist Bioscience has a consensus price target of $52.80, indicating a potential upside of 31.68%. Given Twist Bioscience's stronger consensus rating and higher possible upside, analysts plainly believe Twist Bioscience is more favorable than Qiagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qiagen 0 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.30Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70 Do insiders & institutionals believe in QGEN or TWST? 70.0% of Qiagen shares are owned by institutional investors. 9.0% of Qiagen shares are owned by insiders. Comparatively, 3.0% of Twist Bioscience shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryQiagen beats Twist Bioscience on 11 of the 18 factors compared between the two stocks. Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TWST vs. The Competition Export to ExcelMetricTwist BioscienceBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.25B$2.95B$5.53B$7.93BDividend YieldN/A1.89%5.11%4.22%P/E Ratio-11.1630.0722.5118.54Price / Sales6.81494.82397.62103.30Price / CashN/A168.6838.1834.62Price / Book4.943.176.734.25Net Income-$208.73M-$72.35M$3.22B$248.18M7 Day Performance-5.98%2.14%1.38%1.03%1 Month Performance-1.31%5.67%2.79%2.70%1 Year Performance17.81%-23.57%15.41%4.05% Twist Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TWSTTwist Bioscience3.618 of 5 stars$40.10+6.3%$52.80+31.7%+18.0%$2.39B$330.19M-11.86990Upcoming EarningsPositive NewsQGENQiagen3.8104 of 5 stars$42.49+1.0%$47.83+12.6%+1.4%$9.45B$1.98B118.316,030Upcoming EarningsGap UpROIVRoivant Sciences2.1957 of 5 stars$11.19+1.6%$17.50+56.4%+3.3%$7.98B$122.59M-74.60860Positive NewsRVMDRevolution Medicines3.7491 of 5 stars$41.47+7.0%$66.67+60.8%+4.7%$7.71B$742,000.00-11.55250Upcoming EarningsPositive NewsLNTHLantheus3.9716 of 5 stars$102.70+0.9%$129.43+26.0%+57.2%$7.03B$1.53B17.09700Upcoming EarningsPositive NewsBBIOBridgeBio Pharma4.5588 of 5 stars$35.89-1.2%$53.00+47.7%+42.1%$6.81B$221.90M-12.59400Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageTGTXTG Therapeutics3.3132 of 5 stars$42.03+1.7%$40.67-3.2%+185.7%$6.67B$329.00M-420.26290Upcoming EarningsPositive NewsLEGNLegend Biotech2.6725 of 5 stars$34.70+1.2%$78.82+127.1%-22.8%$6.37B$627.24M-36.531,070SRPTSarepta Therapeutics4.7589 of 5 stars$61.51+1.8%$158.70+158.0%-52.0%$5.97B$1.90B49.21840Upcoming EarningsTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$17.57-6.5%$22.00+25.2%N/A$5.94B$783.21M0.00N/AAnalyst RevisionNews CoverageGap DownHigh Trading VolumeADMAADMA Biologics1.4562 of 5 stars$24.51+12.1%$22.50-8.2%+248.9%$5.82B$426.45M87.54530Upcoming EarningsOptions VolumePositive NewsGap UpHigh Trading Volume Related Companies and Tools Related Companies Qiagen Alternatives Roivant Sciences Alternatives Revolution Medicines Alternatives Lantheus Alternatives BridgeBio Pharma Alternatives TG Therapeutics Alternatives Legend Biotech Alternatives Sarepta Therapeutics Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives ADMA Biologics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TWST) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TWST Stock Free TWST Stock Alerts